WO2002062259A2 - Method for alteration of iris pigment - Google Patents
Method for alteration of iris pigment Download PDFInfo
- Publication number
- WO2002062259A2 WO2002062259A2 PCT/US2001/029481 US0129481W WO02062259A2 WO 2002062259 A2 WO2002062259 A2 WO 2002062259A2 US 0129481 W US0129481 W US 0129481W WO 02062259 A2 WO02062259 A2 WO 02062259A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- iris
- color
- pigment
- laser beam
- iris color
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00876—Iris
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00802—Methods or devices for eye surgery using laser for photoablation
Definitions
- Iris color in humans varies widely between ethnic groups and between individuals. Iris color of a normal human is dependent on the presence and density of colored pigment in pigment cells in the iris.
- the colored pigment exists in more than one form, for example, the brown pigment eumelanin and the yellow pigment pheomelanin.
- Iris pigment epithelial cells containing the pigment eumelanin are present in both the anterior layer of the iris and in the deeper superficial stroma of the iris, while iris pigment epithelial cells containing the pigment pheomelanin are primarily present in the superficial stroma of the iris.
- a complete lack of iris pigment results in a pink color due to the coloration of vascular components of the iris stroma.
- Very low pigment density causes the scatter of white light passing through the iris and is as blue, a process similar to the scatter in the atmosphere resulting in a blue sky.
- the remaining iris colors result from the increasing density of one or more of the forms of iris pigment.
- alteration of some types of iris color has become possible through the use of colored contact lenses.
- Such colored contact lenses can have a prescriptive optical power, or can be optically neutral such that the lenses serves a cosmetic function only.
- the lenses have the same potential complications of use as contact lenses with prescriptive optical powers, including allergic reactions to the lens material and infections from improper handling. Further, contact lenses cannot be tolerated by some potential users due to the discomfort. Additionally, colored contact lenses require a degree of dexterity to insert and remove that is not possessed by all potential users. Further, permanent changes in iris color cannot be achieved through the use of colored contact lenses.
- Another method for altering iris color involves the use of colored lens implanted anterior to the iris. Such implants require an invasive procedure to place the lens in position. Because of the potential complication of an invasive procedure and of leaving a foreign body within the eye, the implantation of color lenses has not become a widely adopted procedure.
- a method for altering iris pigment in a human or animal thereby altering iris color of a first iris from a first iris color to a second iris color.
- the method comprises, first, selecting one or more than one laser capable of generating one or more than one laser beam that will remove substantially similar amounts of iris pigment of at least two different iris pigment colors from the first iris, and then applying the one or more than one laser beam to the first iris of a first iris color to remove the iris pigment.
- the removal of the iris pigment causes an alteration in the color of the first iris from the first iris color to the second iris color.
- the second iris color is substantially the same hue as the first iris color but is less saturated than the first iris color, or the second iris color is both a different hue and less saturated than the first iris color.
- the human or animal is a human patient, and the method further comprises consulting with the patient to determine the second iris color before applying the one or more than one laser beam.
- the method further comprises repeating the selecting and applying steps at least one day after applying the one or more than one laser beam.
- the method further comprises repeating the selecting and applying steps at after a time between about 1 day and about 2 years after applying the one or more than one laser beam.
- the method further comprises repeating the selecting and applying steps at least one day after a time between about 1 week and about 1 month after applying the one or more than one laser beam.
- the second iris color does not naturally occur in a human iris.
- the method further comprises creating an opening in the cornea of the human or animal before applying the one or more than one laser beam, and then applying the one or more than one laser beam through the opening.
- the one or more than one laser selected is a pulse dye laser.
- the one or more than one laser beam generated has a wavelength of between about 300 nm and about 900 nm.
- the method further comprises altering iris pigment in the human or animal, thereby altering iris color of a second iris from a third iris color to a fourth iris color.
- the method comprises selecting one or more than one laser capable of generating one or more than one laser beam that will remove iris pigment from the second iris, and then, applying the one or more than one laser beam to the second iris of the third iris color to remove iris pigment.
- the removal of the iris pigment of the second selected color causes an alteration in the color of the second iris from the third iris color to the fourth iris color.
- the second iris color is substantially same as the fourth iris color.
- the second iris color is substantially different than the fourth iris color.
- the method comprises selecting one or more than one laser capable of generating one or more than one laser beam that will selectively remove iris pigment substantially of only a first pigment color, or that will remove iris pigment substantially uniformly of all iris pigment colors to decrease the overall density of all colors of iris pigment, or that will remove iris pigment of a first pigment color and a second pigment color while removing more iris pigment of the first pigment color than iris pigment of the second pigment color.
- the one or more than one laser beam is applied to an iris of a first iris color to remove iris pigment.
- the removal of iris pigment causes an alteration in the color of the iris from the first iris color to the second iris color, where the second iris color is a different hue than the first iris color, or is a different saturation than the first iris color or is both a different hue and a different saturation than the first iris color.
- a method for altering the iris pigment in the iris of an animal or a human to change the color of the iris from a first iris color to a second iris color is performed as follows. First, the human patient or animal is examined and, if a human patient, a determination is made in consultation with the human patient as to the patient's desired iris color. Next, a determination is made as to whetlier the patient's desired iris color can be obtained using the method of the present invention by virtue of laser alteration of the patient's existing iris pigment as will be understood by those in the art with reference to this disclosure.
- laser alteration of the patient's iris pigment using the present method can alter the patient's irises to green.
- laser alteration of the patient's iris pigment using the present method can alter the patient's irises to less saturated brown irises.
- laser alteration of the patient's iris pigment using the present method can alter the patient's irises to less saturated green irises.
- the method comprises selecting one or more than one laser capable of generating one or more than one laser beam.
- the one or more than one laser beam is selected that will either selectively remove iris pigment substantially of only a first selected pigment color, or that will remove iris pigment substantially uniformly of all iris pigment colors to decrease the overall density all colors of iris pigment, or that will remove iris pigment of a first pigment color and a second pigment color while removing more iris pigment of the first pigment color than iris pigment of the second pigment color.
- the second iris color is the substantially the same hue but less saturated than the first iris color
- the one or more than one laser is selected that will remove iris pigment substantially uniformly of all iris pigment colors to decrease the overall density of all colors of iris pigment.
- the second iris color is a different hue than the first iris color
- the one or more than one laser is selected that will selectively remove iris pigment substantially of only a first selected pigment color.
- the one or more than one laser is selected that will remove iris pigment of a first pigment color and a second pigment color while removing more iris pigment of the first pigment color than iris pigment of the second pigment color, depending on the first iris color and the desired second iris color, as will be understood by those in the art with reference to this disclosure.
- the one or more than one laser beam is applied to the iris of the first iris color at a sufficient intensity and for a sufficient time to remove iris pigment, where the removal of the iris pigment causes an alteration in the color of the iris from the first iris color to the second iris color.
- the laser beams can be applied sequentially or simultaneously.
- the second iris color is a different hue than the first iris color, or is substantially the same hue as the first iris color but less saturated than the first iris color, or is both a different hue and less saturated than the first iris color.
- iris pigment of a patient to result in an iris color which is not naturally occurring, such as violet, or to alter iris pigment differently between two eyes of a patient to result in the patient having irises of different colors by differentially treating each iris of a patient according to one method of the present invention or by treating only one iris of the patient according to the present invention.
- the intensity of the laser beam is set to a level that minimizes the damage to any ocular tissue while still allowing satisfactory removal of the required iris pigment.
- the method of the present invention can further include creating an opening in the cornea of the human before applying the one or more than one laser beam, and then applymg the one or more than one laser beam through the opening in order to minimize damage to the anterior ocular structures. If necessary, a temporary contact lens can be applied to reduce post- procedure discomfort.
- the method of the present invention can be repeated at a time spaced apart from the original application of the one or more than one laser, in order to further alter the iris pigment, after allowing the iris and associated tissue to heal from the original application.
- the method can be repeated at least one day after applying the one or more than one laser beam to the iris.
- the method is repeated at a time between about 1 day and about 2 years after applying the one or more than one laser beam to the iris.
- the method is repeated at a time between about 1 week and about 1 month after applying the one or more than one laser beam to the iris.
- the use of lasers to remove iris pigment is advantageous because specific lasers can be selected which create laser beams which are selectively absorbed by iris pigment of specific colors. This property allows the selection of lasers to selectively destroy iris pigment of specific colors while not destroying iris pigment of other colors.
- the one or more than one laser beam generated could be selected to substantially remove only eumelanin or substantially remove only pheomelanin.
- one or more than one laser beam can be selected to remove iris pigment substantially uniformly of all iris pigment colors to decrease the overall density all colors of iris pigment.
- the one or more than one laser beam can be selected to remove iris pigment of a first pigment color and a second pigment color while removing more iris pigment of the first pigment color than iris pigment of the second pigment color.
- the one or more than one laser selected is a pulse dye lasers because the wavelength of the laser beam is determined by the color of the material through which the laser beams pass. This advantageously increases the specificity of iris pigment destruction by the laser beams by selecting appropriate dyes. Moreover, the intensity of the laser beams can be adjusted to minimize damage to ocular tissue and iris pigments that are not specifically targeted.
- the one or more than one laser is a pulse dye laser and the wavelength generated by the one or more than one laser is between about 300 nm and about 900 nm.
- suitable lasers includes the Due-220, DUO-221, and the DUO-210 models, as well as the DYE 120, the DYE 121, and the DYE 110 models ( Laser Science, Inc., Franklin, MA US).
- the one or more than one laser selected is a modified excimer laser which permits the operator to alter the nature and quantity of the material through which the laser beam passes.
- the one or more than one excimer laser will generate a wavelength of between about 100 nm and 250 nm.
- the ArF excimer laser used in ophthalmic photoablation produces a beam of ultraviolet light with a wavelength of 193 nm.
- the ArF excimer laser beam passes though a specified quantity of argon fluoride, and both the material and its quantity can be modified to achieve the desired wavelength.
- LaserSight Technologies, Inc. (Winter Park, FL US) has devised two solid state lasers: the LaserHarmonic-1 and LaserHarmonic-2.
- the LaserHarmonic-1 is flash lamp pumped and employs the fifth harmonic of a Nd:Yag at 213 nm.
- the LaserHarmonic-2 is a diode pumped fifth harmonic Nd:YLF laser at 209 nm. While a pulse dye laser or an excimer laser are preferred, other lasers can be used in the present method..
- EXAMPLE I One method of the present invention is performed as follows. An adult male patient is selected who desires to change his brown iris color to green. He is found in satisfactory general and ocular health. After being counseled regarding the procedure and being prepared, a suitable laser is selected and is applied to each iris through the patient's intact corneas to remove pigment present in his irises until the remaining iris pigment is to render his irises green.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002436041A CA2436041A1 (en) | 2001-02-02 | 2001-09-20 | Method for alteration of iris pigment |
BR0116859-2A BR0116859A (en) | 2001-02-02 | 2001-09-20 | Iris pigment modification method |
IL15712901A IL157129A0 (en) | 2001-02-02 | 2001-09-20 | A method for altering iris pigment |
EP01971253A EP1363546A4 (en) | 2001-02-02 | 2001-09-20 | Method for alteration of iris pigment |
US10/466,963 US20040073199A1 (en) | 2001-02-02 | 2001-09-20 | Method for alteration of iris pigment |
AU2001291157A AU2001291157B2 (en) | 2000-02-03 | 2001-09-20 | Method for alteration of iris pigment |
MXPA03006923A MXPA03006923A (en) | 2001-02-02 | 2001-09-20 | Method for alteration of iris pigment. |
US13/531,219 US20120265180A1 (en) | 2001-09-20 | 2012-06-22 | Altering Iris Color |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/003569 WO2001056518A1 (en) | 2000-02-03 | 2001-02-02 | Method for alteration of iris pigmentation |
US09/776,345 | 2001-02-02 | ||
US09/776,345 US6306127B2 (en) | 2000-02-03 | 2001-02-02 | Method for alteration of iris pigmentation |
USPCT/US01/03569 | 2001-02-02 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10466963 A-371-Of-International | 2001-09-20 | ||
US10/962,241 Continuation-In-Part US8206379B2 (en) | 2001-02-02 | 2004-10-08 | Techniques for alteration of iris pigment |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002062259A2 true WO2002062259A2 (en) | 2002-08-15 |
WO2002062259A3 WO2002062259A3 (en) | 2003-05-01 |
Family
ID=26680408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/029481 WO2002062259A2 (en) | 2000-02-03 | 2001-09-20 | Method for alteration of iris pigment |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1363546A4 (en) |
BR (1) | BR0116859A (en) |
CA (1) | CA2436041A1 (en) |
CZ (1) | CZ20032333A3 (en) |
IL (1) | IL157129A0 (en) |
MX (1) | MXPA03006923A (en) |
RU (1) | RU2003126916A (en) |
WO (1) | WO2002062259A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120265180A1 (en) * | 2001-09-20 | 2012-10-18 | Stroma Medical Corporation | Altering Iris Color |
EP3308758A1 (en) * | 2016-10-12 | 2018-04-18 | A.R.C. Laser GmbH | Method and apparatus for changing the perceptual color appearance of the iris of a human's or animal's eye |
US11160685B1 (en) | 2021-03-24 | 2021-11-02 | Stroma Medical Corporation | Laser systems and methods for alteration of eye color |
US11259962B1 (en) | 2021-03-24 | 2022-03-01 | Stroma Medical Corporation | Systems and methods for patient alignment and treatment |
US11273074B1 (en) | 2021-03-24 | 2022-03-15 | Stroma Medical Corporation | Systems and methods for for physical and electronic security of medical devices |
US11278452B1 (en) | 2021-03-24 | 2022-03-22 | Stroma Medical Corporation | Systems and methods for eye imaging and position control |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4641349A (en) * | 1985-02-20 | 1987-02-03 | Leonard Flom | Iris recognition system |
US5312395A (en) * | 1990-03-14 | 1994-05-17 | Boston University | Method of treating pigmented lesions using pulsed irradiation |
US5549596A (en) * | 1993-07-07 | 1996-08-27 | The General Hospital Corporation | Selective laser targeting of pigmented ocular cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5520679A (en) * | 1992-12-03 | 1996-05-28 | Lasersight, Inc. | Ophthalmic surgery method using non-contact scanning laser |
DE69908232T2 (en) * | 1998-03-31 | 2004-04-01 | Nidek Co., Ltd., Gamagori | Laser treatment device |
-
2001
- 2001-09-20 MX MXPA03006923A patent/MXPA03006923A/en unknown
- 2001-09-20 EP EP01971253A patent/EP1363546A4/en not_active Ceased
- 2001-09-20 CA CA002436041A patent/CA2436041A1/en not_active Abandoned
- 2001-09-20 BR BR0116859-2A patent/BR0116859A/en not_active IP Right Cessation
- 2001-09-20 RU RU2003126916/14A patent/RU2003126916A/en not_active Application Discontinuation
- 2001-09-20 IL IL15712901A patent/IL157129A0/en unknown
- 2001-09-20 CZ CZ20032333A patent/CZ20032333A3/en unknown
- 2001-09-20 WO PCT/US2001/029481 patent/WO2002062259A2/en active Search and Examination
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4641349A (en) * | 1985-02-20 | 1987-02-03 | Leonard Flom | Iris recognition system |
US5312395A (en) * | 1990-03-14 | 1994-05-17 | Boston University | Method of treating pigmented lesions using pulsed irradiation |
US5549596A (en) * | 1993-07-07 | 1996-08-27 | The General Hospital Corporation | Selective laser targeting of pigmented ocular cells |
Non-Patent Citations (1)
Title |
---|
See also references of EP1363546A2 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120265180A1 (en) * | 2001-09-20 | 2012-10-18 | Stroma Medical Corporation | Altering Iris Color |
EP3308758A1 (en) * | 2016-10-12 | 2018-04-18 | A.R.C. Laser GmbH | Method and apparatus for changing the perceptual color appearance of the iris of a human's or animal's eye |
WO2018069014A1 (en) * | 2016-10-12 | 2018-04-19 | A.R.C. Laser Gmbh | Method and apparatus for changing the perceptual color appearance of the iris of a human's or animal's eye |
US11160685B1 (en) | 2021-03-24 | 2021-11-02 | Stroma Medical Corporation | Laser systems and methods for alteration of eye color |
US11259962B1 (en) | 2021-03-24 | 2022-03-01 | Stroma Medical Corporation | Systems and methods for patient alignment and treatment |
US11273074B1 (en) | 2021-03-24 | 2022-03-15 | Stroma Medical Corporation | Systems and methods for for physical and electronic security of medical devices |
US11278452B1 (en) | 2021-03-24 | 2022-03-22 | Stroma Medical Corporation | Systems and methods for eye imaging and position control |
Also Published As
Publication number | Publication date |
---|---|
EP1363546A2 (en) | 2003-11-26 |
CA2436041A1 (en) | 2002-08-15 |
WO2002062259A3 (en) | 2003-05-01 |
MXPA03006923A (en) | 2003-11-18 |
EP1363546A4 (en) | 2004-06-16 |
RU2003126916A (en) | 2005-02-20 |
BR0116859A (en) | 2004-01-13 |
IL157129A0 (en) | 2004-02-08 |
CZ20032333A3 (en) | 2003-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120265180A1 (en) | Altering Iris Color | |
US6989008B2 (en) | Adjustable ablatable inlay | |
JP4757946B2 (en) | Device for incremental correction of visual impairment and eye disease | |
US6551307B2 (en) | Vision correction using intrastromal pocket and flap | |
EP1534188B1 (en) | Optical Corneal Implant | |
US20080015660A1 (en) | Method And Apparatus For Photo-Chemical Oculoplasty/Keratoplasty | |
US6306127B2 (en) | Method for alteration of iris pigmentation | |
US20090312749A1 (en) | Optical fiber laser device for ocular suturing | |
JPH01297060A (en) | Apparatus for mounting synthetic lens for correcting sight to freely control contour thereof | |
Lanzetta et al. | Early vascular changes induced by transpupillary thermotherapy of choroidal neovascularization | |
EP1363546A2 (en) | Method for alteration of iris pigment | |
US20200093636A1 (en) | Iris color changing method | |
US20040073199A1 (en) | Method for alteration of iris pigment | |
AU2001291157B2 (en) | Method for alteration of iris pigment | |
AU2003241638B2 (en) | Method for alteration of iris pigment | |
AU2001291157A1 (en) | Method for alteration of iris pigment | |
ZA200306813B (en) | Method for alteration of iris pigment. | |
AU2004201031A1 (en) | Method for alteration of iris pigment | |
Watts et al. | The use of Q-switched Nd: YAG laser for removal of permanent eyeliner tattoo | |
RU2739995C1 (en) | Method for conducting ultraviolet corneal cross-linking using biolens with thin cornea | |
WO2005036214A2 (en) | Techniques for alteration of iris pigment | |
Serafetinides et al. | Alternatives to excimer laser refractive surgery: UV and mid-infrared laser ablation of intraocular lenses and porcine cornea | |
JP2007517558A (en) | Apparatus and method for treating corneal neovascularization or vascular deposition on the conjunctiva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10466963 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2436041 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 157129 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/006923 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001971253 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001291157 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 527859 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-2333 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/06813 Country of ref document: ZA Ref document number: 200306813 Country of ref document: ZA |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-2333 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 2001971253 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001291157 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWR | Wipo information: refused in national office |
Ref document number: 2001971253 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001971253 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: PV2003-2333 Country of ref document: CZ |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |